Introduction
LumiSTAR is developing innovative pipelines of cell therapies based on induced pluripotent stem cell (iPSC) technology. These therapies have the potential to revolutionize treatment for a wide range of diseases, including Parkinson’s disease, kidney failure, and cancer.
Features / strengths
■ Our iPSC Cell Therapy Pipelines:
• Parkinson’s Disease
• Chronic Kidney Disease
• Solid Tumors (iPSC-NK)
Specification in detail
